Product Code: ETC13385842 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Pneumonia Vaccine Market was valued at USD 2400 Billion in 2024 and is expected to reach USD 4200 Billion by 2031, growing at a compound annual growth rate of 7.30% during the forecast period (2025-2031).
The Global Pneumonia Vaccine Market is witnessing steady growth driven by increasing awareness about the importance of vaccination, growing prevalence of pneumonia, and the focus on preventive healthcare. The market is characterized by the presence of key players such as Pfizer, GlaxoSmithKline, Merck & Co., Inc., and Sanofi Pasteur, who are actively engaged in research and development activities to introduce new and improved vaccines. The market is segmented based on vaccine type (pneumococcal conjugate vaccines and pneumococcal polysaccharide vaccines), distribution channel (hospitals, clinics, pharmacies), and geography. With the rising geriatric population, increasing government initiatives for vaccination programs, and expanding healthcare infrastructure in developing economies, the Global Pneumonia Vaccine Market is expected to continue its growth trajectory in the coming years.
The Global Pneumonia Vaccine Market is witnessing growth due to increasing awareness about the importance of vaccination, rising prevalence of pneumonia, and government initiatives to control the disease. The market is experiencing a shift towards the development of advanced vaccines with improved efficacy and fewer side effects. Opportunities lie in the expansion of vaccination programs in developing countries, the introduction of new vaccines targeting different strains of pneumonia-causing bacteria, and the growing elderly population at higher risk of contracting the disease. Additionally, collaborations between pharmaceutical companies and research institutions for vaccine development and technological advancements in vaccine production processes are driving market growth. Overall, the Global Pneumonia Vaccine Market is poised for further expansion and innovation in the coming years.
The Global Pneumonia Vaccine Market faces several challenges, including limited access to vaccines in low-income countries due to high costs and inadequate healthcare infrastructure, particularly in rural areas. Additionally, there are issues related to vaccine effectiveness against evolving strains of pneumonia-causing bacteria, leading to the need for continuous research and development. Regulatory hurdles and stringent approval processes also pose challenges for vaccine manufacturers looking to introduce new products in the market. Furthermore, vaccine hesitancy and misinformation about vaccination among certain populations can impede the uptake of pneumonia vaccines, affecting overall market growth. Addressing these challenges will require collaboration between governments, healthcare organizations, and vaccine manufacturers to improve access, affordability, and awareness about pneumonia vaccination.
The global pneumonia vaccine market is primarily driven by increasing awareness about the importance of vaccination in preventing pneumonia, coupled with rising government initiatives to promote vaccination programs. The growing elderly population, who are more susceptible to pneumonia, is also a key driver as well as the increasing prevalence of pneumonia cases globally. Technological advancements in vaccine development and increasing research activities in the field of immunology are further propelling the market growth. Additionally, the high demand for pneumonia vaccines in developing countries due to the lack of proper healthcare infrastructure and the rising burden of pneumonia-related deaths are contributing to the market expansion.Overall, the rising focus on preventive healthcare measures and the continuous efforts to reduce the burden of pneumonia are the key drivers shaping the global pneumonia vaccine market.
Government policies related to the Global Pneumonia Vaccine Market focus on increasing access to vaccination programs, particularly in low- and middle-income countries where the burden of pneumonia is high. Many governments have implemented immunization schedules that include pneumonia vaccines as part of routine vaccinations for children. Additionally, some governments provide subsidies or free vaccinations to ensure widespread coverage and reduce the economic barriers to access. Regulatory bodies also play a crucial role in ensuring the safety and efficacy of pneumonia vaccines through rigorous approval processes. Overall, government policies aim to address the public health impact of pneumonia by promoting vaccination programs and fostering collaboration with vaccine manufacturers to ensure affordable and equitable access to vaccines globally.
The Global Pneumonia Vaccine Market is expected to witness significant growth in the coming years, driven by rising awareness about preventive healthcare and the increasing prevalence of pneumonia worldwide. The market is projected to expand further due to government initiatives to promote vaccination programs, advancements in vaccine technology, and a growing elderly population. Additionally, the ongoing research and development activities aimed at developing more effective and affordable pneumonia vaccines are anticipated to contribute to market growth. However, challenges such as high costs associated with vaccine development and distribution, as well as limited access to healthcare in some regions, may hinder the market`s full potential. Overall, with an increasing focus on immunization and disease prevention, the Global Pneumonia Vaccine Market is expected to show promising growth opportunities in the foreseeable future.
In the Global Pneumonia Vaccine Market, North America and Europe lead in terms of revenue due to high healthcare expenditure, advanced healthcare infrastructure, and strong government support for immunization programs. Asia-Pacific is expected to witness significant growth driven by the increasing awareness about pneumonia prevention, rising disposable income, and expanding healthcare infrastructure in countries like China and India. The Middle East and Africa region is also anticipated to show growth, supported by government initiatives to improve vaccination coverage and reduce the burden of pneumonia. Latin America is projected to experience moderate growth due to increasing healthcare investments and a growing focus on preventive healthcare measures. Overall, the global pneumonia vaccine market is expected to expand across all regions, driven by the increasing prevalence of pneumonia and the growing emphasis on vaccination programs.
Global Pneumonia Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Pneumonia Vaccine Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Pneumonia Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Global Pneumonia Vaccine Market - Industry Life Cycle |
3.4 Global Pneumonia Vaccine Market - Porter's Five Forces |
3.5 Global Pneumonia Vaccine Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Pneumonia Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Global Pneumonia Vaccine Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 Global Pneumonia Vaccine Market Revenues & Volume Share, By Sector, 2021 & 2031F |
3.9 Global Pneumonia Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Pneumonia Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Pneumonia Vaccine Market Trends |
6 Global Pneumonia Vaccine Market, 2021 - 2031 |
6.1 Global Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Pneumonia Vaccine Market, Revenues & Volume, By Pneumococcal Conjugate Vaccine, 2021 - 2031 |
6.1.3 Global Pneumonia Vaccine Market, Revenues & Volume, By Pneumococcal Polysaccharide Vaccine, 2021 - 2031 |
6.2 Global Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Pneumonia Vaccine Market, Revenues & Volume, By Prevnar 13, 2021 - 2031 |
6.2.3 Global Pneumonia Vaccine Market, Revenues & Volume, By Synflorix, 2021 - 2031 |
6.2.4 Global Pneumonia Vaccine Market, Revenues & Volume, By Pneumovax 23, 2021 - 2031 |
6.3 Global Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Pneumonia Vaccine Market, Revenues & Volume, By Public, 2021 - 2031 |
6.3.3 Global Pneumonia Vaccine Market, Revenues & Volume, By Private, 2021 - 2031 |
6.4 Global Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Pneumonia Vaccine Market, Revenues & Volume, By Distribution Partner Companies, 2021 - 2031 |
6.4.3 Global Pneumonia Vaccine Market, Revenues & Volume, By Non-governmental Organizations (NGO), 2021 - 2031 |
6.4.4 Global Pneumonia Vaccine Market, Revenues & Volume, By Government Authorities, 2021 - 2031 |
7 North America Pneumonia Vaccine Market, Overview & Analysis |
7.1 North America Pneumonia Vaccine Market Revenues & Volume, 2021 - 2031 |
7.2 North America Pneumonia Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.4 North America Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.5 North America Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
7.6 North America Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Pneumonia Vaccine Market, Overview & Analysis |
8.1 Latin America (LATAM) Pneumonia Vaccine Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Pneumonia Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
8.4 Latin America (LATAM) Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.5 Latin America (LATAM) Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
8.6 Latin America (LATAM) Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Pneumonia Vaccine Market, Overview & Analysis |
9.1 Asia Pneumonia Vaccine Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Pneumonia Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
9.4 Asia Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.5 Asia Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
9.6 Asia Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Pneumonia Vaccine Market, Overview & Analysis |
10.1 Africa Pneumonia Vaccine Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Pneumonia Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
10.4 Africa Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.5 Africa Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
10.6 Africa Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Pneumonia Vaccine Market, Overview & Analysis |
11.1 Europe Pneumonia Vaccine Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Pneumonia Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
11.4 Europe Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.5 Europe Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
11.6 Europe Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Pneumonia Vaccine Market, Overview & Analysis |
12.1 Middle East Pneumonia Vaccine Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Pneumonia Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Pneumonia Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Pneumonia Vaccine Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
12.4 Middle East Pneumonia Vaccine Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.5 Middle East Pneumonia Vaccine Market, Revenues & Volume, By Sector, 2021 - 2031 |
12.6 Middle East Pneumonia Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Pneumonia Vaccine Market Key Performance Indicators |
14 Global Pneumonia Vaccine Market - Export/Import By Countries Assessment |
15 Global Pneumonia Vaccine Market - Opportunity Assessment |
15.1 Global Pneumonia Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Pneumonia Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
15.3 Global Pneumonia Vaccine Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.4 Global Pneumonia Vaccine Market Opportunity Assessment, By Sector, 2021 & 2031F |
15.5 Global Pneumonia Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Pneumonia Vaccine Market - Competitive Landscape |
16.1 Global Pneumonia Vaccine Market Revenue Share, By Companies, 2024 |
16.2 Global Pneumonia Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |